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Introduction
It is now well recognised that sexual health is important to overall 
health and well-being.1 Sexual performance carries a sense of 
identity and self-esteem for men and results in anxiety when sexual 
ability declines.2 Despite substantial progress in the treatment 
of erectile dysfunction (ED) and available treatment facilities 
throughout the world, low treatment-seeking behaviour could be 
attributed to the sensitivity and social stigma associated with ED,3 as 
well as the cost, lack of availability and side-effects that are linked 
to pharmacological treatment.4,5  It is estimated that the global 
prevalence of ED will be 322 million by the year 2025.6,7 According 
to Fazio and Brock,8 the ageing global population, decreasing social 
stigma associated with ED, and increasing availability of effective 
oral treatment, has increased the number of patients presenting with 
this condition. 
In a study conducted on Ethiopian men with diabetes, 79% of 
patients never complained about ED.9 However, it is a common 
secondary side-effect of a number of noncommunicable diseases. 
Motorsi et al10 explain that ED exists approximately 39 months 
before cardiac events and the relationship between cardiovascular 
disease (CVD) and ED has been firmly established.11-13 The presence 
of ED predicted the onset of CVD events in men with type 2 diabetes 
without clinically explicit CVD.14 
Evidence generated by epidemiological studies found modifiable 
risk factors, such as physical activity and leanness, to be associated 
with a reduced risk for the development of ED. Obesity was found to 
be a risk factor for its development.5 Logistical regression analysis 
indicated fasting blood glucose levels and waist circumference 
measurement to be the most important predictors of the development 
of ED. Therefore, it would seem that metabolic syndrome (MS) is 
an additional risk factor for the development of ED.15-17 A review 
that documented the relationship between MS and ED confirmed a 
reciprocal relationship in that MS is associated with ED, while MS 
can be viewed as a risk factor for the development of ED.18 The 
prevalence of ED in patients with diabetes varies, but can be as high 
as 90%, depending on the assessment method19-21 as the risk of 
ED increases with the duration of the condition and with increasing 
levels of glycosylated haemoglobin.20,22  
The prevalence of ED increases with age. The prevalence of 
complete or severe ED was 5% and moderate ED 17% in a large 
cross-sectional, community-based survey conducted on men aged 
40-49 years of age.23 The prevalence increased to 15% and 34% 
respectively, in older men aged 70-79 years of age. 9.6% of the 
subjects reported complete ED.24 In 2000, the overall prevalence 
of ED in the same study population was re-estimated to be 44%.25 
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However, ED cannot be viewed as an inevitable result of ageing, 
as 54% of the healthy and 41% of the diseased men in the oldest 
age category of the study sample (65-70 years) did not complain of 
moderate or severe ED.26
Ischaemic strokes and smoking are associated with ED. (The 
prevalence of ED is twice as high in smokers as it is in non-
smokers).27 Prescription, as well as non-prescription medication, may 
also cause or contribute to ED in 25% of treatment-seeking men.28 
The medication in question may include diuretics, antihypertensive 
and cholesterol-lowering medication, antidepressants and 
tranquilisers.8,29  
The risk factors for ED are multifactorial and complex, and in most 
instances inter-related to lifestyle.27,30-32 In addition, not all risk 
factors follow the same mechanism of causation.32 MS associated 
with a Western lifestyle, as well as endothelial dysfunction and 
downregulation of nitric oxide synthase on a biochemical level, 
is suspected to be a leading cause of ED.31 CVD, in general, is 
also associated with possible endothelial dysfunction in penile 
vasculature.32 Some of the risk factors associated with CVD are 
also linked to the onset of ED, such as smoking, that leads to 
possible endothelial dysfunction, associated atherosclerosis and 
sympathetic overactivity.27 Diabetes mellitus promotes the onset of 
ED via vasculopathy from endothelial dysfunction and autonomic 
neuropathy.32 Ischaemic strokes follow a different pathway, 
causing disruption of descending neural control of the proerectile 
processes.32 The contribution of depression and stress, even though 
they are significant contributors, is not very well understood.32
In most instances, the treatment of ED relies on lifestyle interventions, 
such as diet, exercise and weight loss in the case of MS, cessation 
of smoking, counselling, and appropriate glycaemic control through 
diet.27,30-32 In other instances, ED is treated in combination with 
drugs, such as the cautious use of phosphodiesterase type 5 (PDE5) 
inhibitor in patients who suffer from vascular disease.29
An estimated 34.8% of men aged 40-70 years have moderate to 
complete ED.33,34 A modern lifestyle and environmental factors, such 
as pollution, have resulted in an increase in male infertility in almost 
every part of the world.35 In South Africa, male infertility accounts for 
40% of total infertility or failure to conceive.36
In a feature published in the popular magazine, Men’s Health, male 
readers were educated on how to assess their risk of developing 
ED. Readers were referred to a case study of a man aged 31 years 
who did not have ED problems yet, but a suggestion was made 
that his “poor diet, sedentary lifestyle and family history would 
eventually catch up with him”, and if he didn’t start exercising or 
eating properly his “sex life expectancy” would be an estimated 10 
years.37 The concept of sexual well-being used to focus on sexually 
transmitted disease and reproductive anxieties, but has broadened 
to (and has perhaps become primarily fixated on) a concern with the 
maintenance and enhancement of sexual desire and performance.38 
Pharmacological management 
The most commonly used therapy for the treatment of ED includes 
oral therapy with PDE5 inhibitors, such as sidenafil (Viagra®). 
However, some patients may not be able to tolerate PDE5 or may 
require a lower dose because of side-effects relating to vasodilation. 
As a result, oral therapy has the potential to induce hypotension, 
cause headaches, flushing, dyspepsia, gastrointestinal symptoms 
and nasal congestion, blurred vision, a rash and back pain.5,8,29,39 
An additional concern, when considering the frequent coexistence of 
ED and CVD, is that PDE5 may result in coronary ischaemia.39  
Nutritional and lifestyle prevention and management 
The Health Professional’s Follow-up study6 found several 
modifiable lifestyle factors, such as physical activity and leanness, 
to be associated with the maintenance of good erectile function. 
For example, men with a body mass index (BMI) of more than 
28.7 kg/m2 were likely to have a 30% increased risk of developing 
ED, as opposed to those with a BMI of 25 or lower. 
Cross-sectional studies40 have also found higher levels of physical 
activity to be associated with a significant reduction in the prevalence 
of ED, and that the prevalence of ED directly relates to overweight 
and obesity. A baseline BMI ≥ 28 kg/m2 significantly predicted 
the development of ED in the long term, while initially overweight 
subjects remained at a high risk of developing ED, despite follow-up 
weight loss.30 A large population-based survey conducted in Brazil26 
found that the prevalence of ED was inversely related to the level of 
physical activity.  
Subjects with cholesterol- and fat-rich diets have been found to be 
more likely to develop ED during follow-up than those with more 
balanced diets. In addition, a lower intake of vegetables, fruit and 
nuts and a lower ratio of monounsaturated to saturated fats was 
evident in men with ED.41 Food intake that is more likely to be 
associated with an increased risk of the development of CVD tends 
to be higher in men with ED, whereas the intake of foods that are 
associated with a decreased risk of CVD tends to be lower.42 
Although epidemiological evidence supports the role of lifestyle 
factors, limited data are available to suggest that the treatment of 
underlying risk factors and coexisting illness through weight loss, 
exercise, stress reduction and smoking cessation may improve 
erectile function.27,30 A randomised trial on 110 obese men with 
moderate ED31 which compared intensive lifestyle changes with an 
educational control, found that approximately a third of the subjects 
in the intervention group recovered normal erectile function during 
the course of the study, compared to less than 10% in the control 
group. Of a sample of middle-aged men with hypertension, those 
who achieved the highest levels of fitness and a reduction in blood 
pressure level were also more likely to show an improvement in 
sexual function. Therefore, these studies indicate that significant 
improvements in sexual function can be expected in patients who 
implement intensive lifestyle changes, including weight loss and 
rigorous exercise, and that are associated with positive changes in 
weight, fitness levels and other markers for cardiovascular health.43
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Esposito et al42 also assessed the effect of changes in lifestyle on 
subjects with ED or who were at an increased risk of developing 
ED. Men who were randomly assigned to the intervention group 
(n = 104) received detailed advice on how to reduce body weight, 
improve their dietary quality and increase physical activity, while 
men in the control group (n = 105) were given general information 
about healthy food choices, and general advice on how to increase 
their level of physical activity. The outcome was that there was a 
statistically significant improvement in erectile function score in the 
intervention group (p-value = 0.015). The effect of the intervention 
was that the restoration of erectile function was most pronounced 
in subjects who implemented comprehensive lifestyle changes. 
In addition, there was a strong correlation between the success 
score and the restoration of erectile function, thereby leading the 
authors to conclude that it is possible to achieve an improvement in 
erectile function in men at risk by means of a nonpharmacological 
intervention that targets weight loss and increased physical activity.42 
The promotion of specific foods and traditional and 
herbal remedies that combat erectile dysfunction 
Many patients self-medicate by resorting to local herbs and OTC 
preparations based on anecdotal evidence in an attempt to manage 
their ED.2 Traditional remedies have been used to treat male 
reproductive disorders in South African men for many years.44 
In addition, alternative remedies, such as rhinoceros horn,2,35,45 are 
a major cause for concern.46 Because of the increasing number of 
men seeking treatment for ED, there is a need to assess the safety 
and biological plausibility of some of the OTC preparations, as well 
as food and drinks, that reportedly enhance sexual desire and/or 
performance.
The word “aphrodisiac” derives from the word “Aphrodite”, the 
Greek goddess of beauty, fertility and love, while an aphrodisiac 
refers to any food, drink or drug that increases sexual desire or 
arouses sexual response.47 The two main types of aphrodisiacs 
include psychophysiological stimuli, such as visual, tactile, olfactory 
and aural, as well as preparations that include food, alcoholic drinks 
and love potions. Historically, many natural substances have been 
known to possess aphrodisiac powers or qualities, and have been 
widely used in Africa and Europe.45 These include Panax ginseng 
(ginseng), Epimedium extract (horny goat weed), the dried remains 
of the Mediterranean cantharides beetle (Spanish fly) and oysters.2,48 
In the USA, the only Food and Drug Administration (FDA)-approved 
natural product for erectile dysfunction is yohimbine, an alkaloid 
isolated from the bark of the yohimbe tree (Pausinystalia yohimbe) 
For the purpose of this review, the aphrodisiac qualities of foods and commercially available products in South Africa, such as alcoholic beverages, 
chilli, chocolate, oysters, cantharides, Epimedium extract, Ginkgo biloba, Panax ginseng and Tribulis terrestris will be reviewed and evaluated. The 
foods and products are summarised in Table I.
Table I: Freely available foods and over-the-counter natural ingredients that are touted to have aphrodisiac properties
Product Description Mechanism Dosage
Alcohol 
consumption
Although not promoted as an aphrodisiac, alcohol is 
known to reduce inhibitions, thereby promoting sexual 
intercourse.49 Male alcoholics often report ED after the 
acute ingestion of large amounts alcohol, while in ED 
sufferers, alcohol is a frequent phenomenon.50
The pharmacological management of ED with PDE5 
inhibitors centres around a mechanism whereby levels 
of PDE5 inhibitors and nitric oxide are increased. These 
effects result in relaxation of the smooth muscle in the 
corpus cavernosum of the penis.8,27,39 Research conducted 
by Wallerath et al51 revealed that the increase in eNOS 
expression and activity brought about by red wine from 
France (and probably other regions), may contribute to the 





Spanish fly (also referred to as cantharides) is the common 
name for a variety of blister beetles that are usually black 
or bronze green in colour.52 
The beetles release an irritating substance, cantharidin, 
that acts as a powerful mucosal irritant and vesicant 
(blister inducing),52 causing irritation of the urethra, with 
resultant vascular congestion and inflammation of the 
erectile tissue.53
Toxic. Not considered 





Chillies are the fruit of the plant Capsicum frutescens and 
are touted to have aphrodisiac qualities.55,56 The spiciness 
of chillies is measured in Scoville heat units, which are 
indicative of the amount of capsicum present.45
This alkaloid stimulates chemoreceptor nerve endings in 
the skin, especially the mucous membranes.55,57 
N/A
Chocolate Cocoa and chocolate are referred to as an aphrodisiac,58-61 
Dillinger et al61 cites Diaz del Castillo (1590), a Spanish 
conquistador who landed on the east coast of Mexico after 
Hernandos Cotéz (1519): “from time to time Montezuma’s 
(ruler of the Aztecs) guard brought him, in cups of pure 
gold, a drink made from the cocoa plant, which they said 
he took before visiting his wives”.  
Bioactive substances in chocolate that may influence 
behaviour include tyramine and phenylethylamine,59,62 
which are similar to amphetamine.62 The unsaturated 
N-acylethanolamines in chocolate, which may activate 
cannabinoid receptors or increase endocannabinoid levels, 
are associated with increased sensitivity and euphoria.60,63 
In addition, the taste and fatty nature of chocolate is 
reported to stimulate the hypothalamus, thereby resulting 
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There are approximately 52 Epimedium species of 
herbaceous flowering plants, also known as rowdy lamb 
herb, bishop’s hat or horny goat weed,64 that have been 
used to treat ED for over 
2 000 years.65
Icariin, the active ingredient,66 increases levels of nitric 
oxide and PDE5 activity. This relaxes the smooth muscle in 
the corpus cavernosum67 as icariin is able to inhibit PDE5 
and PDE4 in vitro.66 Liu et al68 found that oral treatment 
with icariin elevated intracavernosal pressure,69,70 while Ma 
et al65 reported that Epimedium may have the potential to 
treat ED as icariin has been screened for pharmacological 
activity in vivo and vitro.65 It has also been reported that 
Epimedium may increase testosterone levels and thyroid 
hormone levels. However, to date, no human studies have 
been conducted.65






Zulu traditional health practitioners have claimed that 
the roots of Eriosema kraussianum and other Eriosema 
species (Zulu indigenous umbrella name of uBangalala) are 
effective in treating ED.47
Isolation of five pyrano-isoflavones from Eriosema 
kraussianum found that the most active of the compounds 
had an activity equal to 75% of that found in Viagra® when 
tested in rabbit models.47
300 mg/day47
Ginkgo biloba Ginkgo biloba is one of the oldest living tree species and 
its leaves are among the most extensively studied herbs in 
use today.71-75
Gingko biloba contains flavonoid glycosides (myricetin 
and quercetin), as well as terpenoids that have been used 
pharmaceutically.71 Properties include the exhibition of 
reversible, nonselective monoamine oxidase inhibition, 
as well as the inhibition of reuptake at the serotonin, 
dopamine and norepinephrine transporters.72 Despite 
conflicting results, Ginkgo biloba extracts may improve 
blood circulation, including microcirculation in small 
capillaries.73-75 
120 mg/day in 
divided doses74,75
Oysters Oysters are propagated as being an excellent aphrodisiac 
as they are a rich source of taurine which has a 
cardioprotective effect and also plays a role in nerve 
transmission.2
The reason for its classification as an aphrodisiac is not 
very clear.76 Some authors34,35,45,48 argue that the alkaloids 
in oysters stimulate the reproductive system and that they 
are a good source of zinc which is involved in the male 




Panax ginseng is an adaptogenic herb,  propagated as 
having the ability to serve as a source of energy, increasing 
testosterone levels and enhancing libido.2,77  
The most commonly used type is Chinese ginseng 
(Panax ginseng), which contains steroids, peptides and 
triterpenoidal D-glucosides (specifically panaxsapogenin), 
and active ingredients referred to as tetracyclic triterpenoid 
saponins (ginsenosides).64,77 Panax ginseng has been 
shown to induce relaxation of the corpus cavernosum in 
male rabbits7,76,78,79 because of mediation by the release 
and/or modification of nitric oxide.64,80 Jang et al81 reported 
that the therapeutic efficacy alluded to by RCTs relates to 
an improvement in ED when compared to a placebo. Side-
effects include insomnia, dermatitis and gastrointestinal 






Tribulis terrestris extract has been used to treat ED in 
China and India for centuries.82
The benefits of the active ingredient, protodioscin, include 
the ability to act as a precursor of testosterone. The 
increase in intracavernosal pressure which confirms the 
proerectile property of Tribulis terrestris can be attributed 
to an increase in testosterone levels and the subsequent 
release of nitric oxide from the nerve endings in the corpus 
cavernosum.82 
85-250 mg three 
times a day82
ED: erectile dysfunction, eNOS: endothelial nitric oxide synthase, N/A: not applicable, PDE5: phosphodiesterase type 5
which is native to tropical West Africa. Yohimbine hydrochloride 
increases libido, but its primary action is to increase blood flow to 
erectile tissue. Contrary to popular misconception, yohimbine has 
no effect on testosterone levels. Although FDA-approved, yohimbe 
has numerous side-effects and contraindications, including 
psychological disorders.
Conclusion
Globally, consumers are taking a more proactive role in their own 
health or disease management. A large proportion of consumers 
embrace alternative “holistic” treatments, particularly herbal or 
phytopharmaceutical products to treat a variety of conditions. 
There is a dearth of systematic scientific evidence of their efficacy 
and safety, when compared to synthesised chemical medicines. 
Standards have yet to be established by regulatory authorities 
with respect to the use of herbal medicines. Therefore, there is an 
urgent need for systematic research to assess the effect of these 
medicines in order to benefit both current users of herbal products 
and to contribute to the development of new therapeutic agents 
for the prevention and management of disease. In addition, there 
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is an urgent need for the protection of human health through the 
implementation of properly validated and analytical state-of-the-art, 
instrument-based methodologies which can chemically characterise 
and quantify the chief chemical constituents of the “remedy”, as 
well as assure its quality and safety. Yet, it is clear from the body of 
scientific evidence that natural ingredients and some freely available 
foods can make a contribution to the traditional, nonpharmacological 
management of ED. However, in many instances, further research 
involving human subjects is required.
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